SCHEMBL17009458

SCHEMBL17009458

c1cncc(Nc2ncnc3nc[nH]c23)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 7/20 0.61
▸ SMN1; SMN2 Q16637 5/20 0.61
▸ HTT P42858 5/20 0.61
▸ HSD17B10 Q99714 3/20 0.61
▸ TSHR P16473 2/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ GFER P55789 1/20 0.61
▸ MKNK1 Q9BUB5 2/20 0.59
▸ NPC1 O15118 6/20 0.57
▸ LMNA P02545 1/20 0.57
▸ TOP2A P11388 2/20 0.56
▸ TNNI3K Q59H18 5/20 0.55
▸ BRAF P15056 3/20 0.54
▸ ROCK1 Q13464 1/20 0.53
▸ MAPT P10636 3/20 0.52
▸ TP53 P04637 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ KMT2A Q03164 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1060507 0.83 MKNK1 (0.72) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4917996 0.76 SMN1; SMN2 (0.71) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4922640 0.76 SMN1; SMN2 (1.00) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4913665 0.76 SMN1; SMN2 (0.71) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4923320 0.76 SMN1; SMN2 (0.71) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4921641 0.75 MKNK1 (0.73) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4922517 0.75 MKNK1 (1.00) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4926098 0.75 MKNK1 (0.73) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4923804 0.75 MKNK1 (0.73) RAB9ASMN1; SMN2HTTHSD17B10TSHR
SCHEMBL4921871 0.73 SMN1; SMN2 (1.00) RAB9ASMN1; SMN2HTTHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3104706-A1 COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE Mitokinin LLC (US) 2016-12-21 — — EP disclosed
WO-2015123365-A1 COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE MITOKININ LLC (US) 2015-08-20 — — WO disclosed
Send feedback